213 related articles for article (PubMed ID: 9738013)
1. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta.
Montano MM; Jaiswal AK; Katzenellenbogen BS
J Biol Chem; 1998 Sep; 273(39):25443-9. PubMed ID: 9738013
[TBL] [Abstract][Full Text] [Related]
2. The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.
Montano MM; Katzenellenbogen BS
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2581-6. PubMed ID: 9122238
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a novel factor that regulates quinone reductase gene transcriptional activity.
Montano MM; Wittmann BM; Bianco NR
J Biol Chem; 2000 Nov; 275(44):34306-13. PubMed ID: 10908561
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
5. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
Bianco NR; Perry G; Smith MA; Templeton DJ; Montano MM
Mol Endocrinol; 2003 Jul; 17(7):1344-55. PubMed ID: 12714703
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications.
Montano MM; Deng H; Liu M; Sun X; Singal R
Oncogene; 2004 Apr; 23(14):2442-53. PubMed ID: 14676828
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
8. hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.
Sripathy SP; Chaplin LJ; Gaikwad NW; Rogan EG; Montano MM
Oncogene; 2008 Oct; 27(49):6376-84. PubMed ID: 18663360
[TBL] [Abstract][Full Text] [Related]
9. Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage.
Bianco NR; Chaplin LJ; Montano MM
Biochem J; 2005 Jan; 385(Pt 1):279-87. PubMed ID: 15456407
[TBL] [Abstract][Full Text] [Related]
10. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
11. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
13. Effects of estrogen on leptin gene promoter activation in MCF-7 breast cancer and JEG-3 choriocarcinoma cells: selective regulation via estrogen receptors alpha and beta.
O'Neil JS; Burow ME; Green AE; McLachlan JA; Henson MC
Mol Cell Endocrinol; 2001 May; 176(1-2):67-75. PubMed ID: 11369444
[TBL] [Abstract][Full Text] [Related]
14. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
15. The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites.
Krishnamurthy N; Ngam CR; Berdis AJ; Montano MM
Oncogene; 2011 Nov; 30(47):4731-9. PubMed ID: 21602889
[TBL] [Abstract][Full Text] [Related]
16. Fisetin induces transcription of NADPH:quinone oxidoreductase gene through an antioxidant responsive element-involved activation.
Hou DX; Fukuda M; Johnson JA; Miyamori K; Ushikai M; Fujii M
Int J Oncol; 2001 Jun; 18(6):1175-9. PubMed ID: 11351248
[TBL] [Abstract][Full Text] [Related]
17. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
18. Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis.
Montano MM; Chaplin LJ; Deng H; Mesia-Vela S; Gaikwad N; Zahid M; Rogan E
Oncogene; 2007 May; 26(24):3587-90. PubMed ID: 17160017
[TBL] [Abstract][Full Text] [Related]
19. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
20. Ellagic acid induces NAD(P)H:quinone reductase through activation of the antioxidant responsive element of the rat NAD(P)H:quinone reductase gene.
Barch DH; Rundhaugen LM
Carcinogenesis; 1994 Sep; 15(9):2065-8. PubMed ID: 7522986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
